ACE527 Safety and Immunogenicity Study

NCT00901654 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Enterotoxigenic E. Coli (ETEC) Infection

Interventions

BIOLOGICAL: ACE527 vaccine
BIOLOGICAL: Placebo vaccine

Sponsor

TD Vaccines A/S

Collaborators

[object Object]
[object Object]